4 (33%) endometrial, 1 (8%) cervical, 1 (8%) uterine sarcoma and 1 (8%) vaginal cancer. Recurrence was localised at vaginal cuff in 5 cases (42%), pelvic lymph nodes in 3 cases (25%), abdominal wall in 2 cases (17%), pelvic peritoneum in 2 cases (17%). Recurrence was dimmed in the surgical field, due to either presence of adherences, or/and deep anatomical position, or/and small size or/and lack of sensitivity. Intraoperative US was able to identify the lesion in all women, allowing MIS (83% laparoscopy and 17% robotic) complete cytoreduction, with no conversion to laparotomy. Median operative time was 150 min (range, 77-280) (including US examination). No intraoperative and postoperative complications occurred. Median length of recovery was 2 days (range, 1-4) and median time to start adjuvant treatment (chemo/radiotherapy) was 25 days (range 22-40 Objectives: To explore contrast enhanced ultrasonography (CEUS) filling patters and quantitative parameters in women with cervical cancer as compared to healthy controls. To assess the diagnostic accuracy of CEUS as compared to conventional gray-scale and power Doppler ultrasound (US) for cervical tumour detection. Methods: Prospective cohort study on 49 women with all stages of cervical cancer and 21 healthy controls. Participants were examined with conventional US followed by CEUS, using 2,5 ml of the intravenous contrast agent Sonovue. Based on saved contrast video-clips we assessed contrast distribution (focal or global) and made quantitative CEUS analyses; peak intensity, time to peak, half wash out, and area under the curve (AUC). Results: Focal contrast distribution (Figure 1 ), was found in 3% (1/32) of the healthy controls/ cancer patients without remaining tumour at surgery vs. in 89% (34/38) of women with remaining tumour at surgery/advanced stage disease. Quantitative analysis showed that reciver operating characteristic (ROC) curve for peak intensity (0.74-0.78, p = 0,004) and for AUC (0.92-0.94 p <0.001) was significantly higher in cancer patients than controls. Conclusions: With CEUS cervical tumours have distinctively different quantitative and qualitative filling pattern as compared to normal cervices. A focal contrast distribution is highly predictive of a remaining tumour at surgery. CEUS might be a valuable tool in selecting women suitable for fertility-sparing surgery. * This presentation is eligible for the Young Investigator award (to be presented in the closing plenary) Objectives: To compare the diagnostic accuracy of ultrasound, CT, and WB-DWI/MRI (whole-body MRI with diffusion-weighted sequence) in ovarian cancer staging. Methods: Patients planned for ovarian cancer surgery at a Gynecologic oncology centre were enrolled. They underwent preoperative staging with ultrasound, CT, and WB-DWI/MRI, following a single predefined evaluation form. Findings were compared to the reference standard (intraoperative and histopathological evaluation forms). The evaluation assessed peritoneal spread in 17 sites and metastatic lymph nodes in 7 sites. Results: Twenty-one patients with ovarian cancer were enrolled between March and August 2016. In 21 patients, 15 (71%) had advanced and 6 (29%) had early stage ovarian cancer. Ultrasound showed the best results in the detection of pelvic carcinomatosis, followed by MRI and CT (AUC 0.87, 0.86, and 0.76, respectively), and in the evaluation of depth of rectosigmoid wall infiltration (AUC 0.85, 0.79, and 0.72). In the abdomen, ultrasound had the best results in the detection of peritoneal carcinomatosis in the upper abdomen (spleen, liver, lesser omentum) and in the greater omentum (AUC of 0.82 and 1.00), in contrast with MRI (AUC 0.73 and 0.93) and CT (AUC 0.71 and 0.88). Ultrasound also reached the highest AUC in the detection of small and large bowel mesentery (AUC 0.78) compared to MRI and CT (AUC 0.66 and 0.62) and was comparable to MRI in the assessment of bowel surface involvement (AUC 0.76), followed by CT (0.73). Ultrasound had the lowest AUC in the detection of parietal carcinomatosis (diaphragm, paracolic gutters, anterior abdominal wall) in comparison to MRI and CT (AUC 0.72, 0.86, and 0.78). In the assessment of retroperitoneal lymph nodes, all three methods showed the similar results (AUC of 0.80). Conclusions: This is the first prospective study to date documenting the potential role of ultrasound in ovarian cancer staging, compared to the method of choice (CT) and a novel technique (WB-DWI/MRI).
Objectives: To explore contrast enhanced ultrasonography (CEUS) filling patters and quantitative parameters in women with cervical cancer as compared to healthy controls. To assess the diagnostic accuracy of CEUS as compared to conventional gray-scale and power Doppler ultrasound (US) for cervical tumour detection. Methods: Prospective cohort study on 49 women with all stages of cervical cancer and 21 healthy controls. Participants were examined with conventional US followed by CEUS, using 2,5 ml of the intravenous contrast agent Sonovue. Based on saved contrast video-clips we assessed contrast distribution (focal or global) and made quantitative CEUS analyses; peak intensity, time to peak, half wash out, and area under the curve (AUC). Results: Focal contrast distribution (Figure 1 ), was found in 3% (1/32) of the healthy controls/ cancer patients without remaining tumour at surgery vs. in 89% (34/38) of women with remaining tumour at surgery/advanced stage disease. Quantitative analysis showed that reciver operating characteristic (ROC) curve for peak intensity (0.74-0.78, p = 0,004) and for AUC (0.92-0.94 p <0.001) was significantly higher in cancer patients than controls. Conclusions: With CEUS cervical tumours have distinctively different quantitative and qualitative filling pattern as compared to normal cervices. A focal contrast distribution is highly predictive of a remaining tumour at surgery. CEUS might be a valuable tool in selecting women suitable for fertility-sparing surgery. * This presentation is eligible for the Young Investigator award (to be presented in the closing plenary) 
